Innate Pharma to Hold its Annual General Meeting of Shareholders on May 28, 2021

The Annual General Meeting will be broadcasted live by the Company

Shareholders are invited to vote at the General Meeting either by mail or by proxy

Marseille, France, April 21, 2021 (GLOBE NEWSWIRE) --  Innate Pharma SA (Euronext Paris: IPH – ISIN: FR0010331421; Nasdaq: IPHA) (“Innate” or the “Company”) will hold its Annual General Meeting of Shareholders (“AGM”) at 11:00 a.m. CET on May 28, 2021. The Annual General Meeting will be broadcasted live.

The procedures for holding the AGM have been adapted in accordance with French Ordinance No. 2020-321 of 25 March 2020 (as modified by French Ordinance n°2020-1497 of December 2, 2020) and French Decree No. 2020-418 of April 10, 2020 (as modified by French Decree No. 2020-1614 of December 18, 2020), extended by French Decree No. 2021-55 of March 9, 2021.

At the date of this publication, administrative measures limiting or prohibiting travel or collective gatherings for health reasons in France prevent the physical presence of its members to the AGM.

In this exceptional context, the shareholders are invited to vote before the AGM by correspondence or through a proxy.

The shareholders will be able to send questions during the AGM. The connection details and the recording will be available on the Company’s website (www.innate-pharma.com).

The Notice of Meeting of this AGM was published on April 21, 2021 in the French legal bulletin. It includes the agenda, the proposed resolutions as well as instructions to participate and vote in this AGM.

All documentation regarding this AGM will be published on the Company’s website.

Precision regarding the AGM:

Only shareholders having registered their shares at least two business days prior to the date of the AGM, by midnight Paris time, will be able to participate.

Shareholders holding “au porteur” (bearer) shares will need to obtain an “attestation de participation” (certificate of shareholding) from their brokers. This “attestation de participation” must be attached to the voting or proxy form.

Written questions from shareholders must be received the second business day prior to the AGM at the latest (by e-mail to [e-mail]).

Shareholders may obtain the legal documentation in preparation of the AGM (as described in article R. 225-83 of the French Code de Commerce) by sending a request by e-mail to [e-mail].

About Innate Pharma:

Innate Pharma S.A. is a global, clinical-stage oncology-focused biotech company dedicated to improving treatment and clinical outcomes for patients through therapeutic antibodies that harness the immune system to fight cancer.